Prospective, single-center, interventional follow-up study to determine the effect of prostate carcinoma and its operative therapy on intraocular pressure and determination of potential mediators.

Diakonie Klinikum Dietrich Bonhoeffer GmbH0 个研究点目标入组 76 人开始时间: 2019年2月11日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•For the test group with prostate cancer
•1. Patients with prostate cancer (all stages) on whom a radical prostatectomy is planned in Neubrandenburg
•2. Willingness of patients to participate in the study with an informed written consent
•For the comparison group
•1. Patient of the eye clinic, male sex
•2. no history of prostate cancer known
•3. PSA value =4.5 ng / ml
•4.Willingness of patients to participate in the study with written consent
•For the test group with breast cancer
•1. Patients with breast cancer (all stages)
•2. Willingness of patients to participate in the study with written consent
•For the test group with colorectal cancer
•1. Patients with colorectal cancer (all stages)
•2. Willingness of patients to participate in the study with written consent

•For all test groups
•1. Glaucoma (anamnesis and HRT examination)
•2. Other eye disease that interferes with an IOP measurement or examination of the anterior segment of the eye
•3. Malignant disease other than prostate cancer, breast cancer and colon cancer (currently or within the last 15 years)
•4. Rheumatologic or autoimmune disease
•5. Allergy to eye drops with local anesthetics, fluorescein and preservatives
•For the comparison group
•1. Glaucoma (anamnesis and HRT examination)
•2. Other eye disease that interferes with IOP measurement or examination of the anterior segment of the eye
•3. Malignant disease (current or within the last 15 years)
•4. Rheumatologic or autoimmune disease
•5. history of prostate cancer
•6. increased PSA value
•7. Allergy to eye drops with local anesthetics, fluorescein and preservatives

发起方